Christophe Gerbeau

744 total citations
27 papers, 498 citations indexed

About

Christophe Gerbeau is a scholar working on Transplantation, Immunology and Epidemiology. According to data from OpenAlex, Christophe Gerbeau has authored 27 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 10 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Christophe Gerbeau's work include Renal Transplantation Outcomes and Treatments (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Christophe Gerbeau is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Christophe Gerbeau collaborates with scholars based in Switzerland, France and United States. Christophe Gerbeau's co-authors include John M. Kovarik, P. Wolf, Arne Schmidt, William M. Bennett, P. R. Rajagopalan, Barry D. Kahan, Laura L. Mulloy, P Lang, G. Mourad and Michael Hall and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Pharmaceutical Research and American Journal of Kidney Diseases.

In The Last Decade

Christophe Gerbeau

26 papers receiving 477 citations

Peers

Countries citing papers authored by Christophe Gerbeau

Since Specialization

Citations

This map shows the geographic impact of Christophe Gerbeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Gerbeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Gerbeau more than expected).

Fields of papers citing papers by Christophe Gerbeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Gerbeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Gerbeau. The network helps show where Christophe Gerbeau may publish in the future.

Co-authorship network of co-authors of Christophe Gerbeau

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Gerbeau. A scholar is included among the top collaborators of Christophe Gerbeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Gerbeau. Christophe Gerbeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Basiliximab in pediatric liver transplantation: A pharmacokinetic‐derived dosing algorithm 2002 ·Pediatric Transplantation ·John M. Kovarik, Bruno Gridelli, Steven R. Martin, Burkhard Rodeck, Michael Melter, Stephen P. Dunn, Robert M. Merion, Andreas G. Tzakis, (unknown), John C. Bucuvalas, Harvey L. Sharp, Christophe Gerbeau, Lawrence Chodoff, Alexander Korn, Michael Hall	26
2	A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1 2002 ·Transplantation ·John M. Kovarik, G. Offner, M. Broyer, Patrick Niaudet, Chantal Loirat, Mark Mentser, Jacques M. Lemire, John F. S. Crocker, Pierre Cochat, Godfrey Clark, Christophe Gerbeau, Lawrence Chodoff, Alexander Korn, Michael Hall	42
3	Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients 2001 ·Clinical Transplantation ·John M. Kovarik, Mark D. Pescovitz, Hans W. Sollinger, Bruce Kaplan, Christophe Legendre, K. Salmela, Benita K. Book, Christophe Gerbeau, (unknown), Kenneth A. Somberg, (unknown)	38
4	POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION 1999 ·Transplantation ·John M. Kovarik, Barry D. Kahan, P. R. Rajagopalan, William M. Bennett, Laura L. Mulloy, Christophe Gerbeau, (unknown)	63
5	Screening for basiliximab exposure–response relationships in renal allotransplantation 1999 ·Clinical Transplantation ·(unknown), Richard H. Moore, P. Wolf, D. Abendroth, David Landsberg, Soulillou Jp, Christophe Gerbeau, (unknown)	35
6	Constructing a Prediction Interval for Time to Reach a Threshold Concentration Based on a Population Pharmacokinetic Analysis: An Application to Basiliximab in Renal Transplantation 1999 ·Journal of Pharmacokinetics and Biopharmaceutics ·France Mentré, John M. Kovarik, Christophe Gerbeau	23
7	DISPOSITION OF BASILIXIMAB, AN IL-2 RECEPTOR (CD25) CHIMERIC MONOCLONAL ANTIBODY, IN PEDIATRIC LIVER TRANSPLANT PATIENTS 1999 ·Transplantation ·John M. Kovarik, Michael Melter, Stephen P. Dunn, A Tzakis, Bruno Gridelli, (unknown), (unknown), Robert M. Merion, Harvey L. Sharp, Christophe Gerbeau, (unknown), Michael Hall	2
8	SOLUBLE INTERLEUKIN-2 RECEPTOR (sIL-2R) PROFILES IN KIDNEY AND LIVER TRANSPLANT PATIENTS RECEIVING BASILIXIMAB (SIMULECT) 1999 ·Transplantation ·John M. Kovarik, Christophe Gerbeau, François Legay, Björn Nashan, Michael Hall	2
9	Pharmacokinetics of Dexamethasone and Valspodar, a P‐glycoprotein (mdr1) Modulator: Implications for Coadministration 1998 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·John M. Kovarik, (unknown), (unknown), Christophe Gerbeau, Henri Humbert, Edgar A. Mueller	15
10	INFLUENCE OF THE DURATION OF IL-2 RECEPTOR (IL-2R) BLOCKADE ON THE INCIDENCE OF ACUTE REJECTION EPISODES IN RENAL TRANSPLANTATION 1998 ·Transplantation ·John M. Kovarik, Christophe Gerbeau, Michael Hall, Arne Schmidt	3
11	DISPOSITION OF BASILIXIMAB, A CHIMERIC IL-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY, IN PEDIATRIC RENAL TRANSPLANT PATIENTS 1998 ·Transplantation ·(unknown), Mark Mentser, (unknown), Chantal Loirat, Jennifer Crocker, G. Offner, Godfrey Clark, Pierre Cochat, (unknown), Christophe Gerbeau, Michael Hall, Arne Schmidt	3
12	CLINICAL IMPACT OF CHIMERIZATION ON THE IMMUNOGENICITY OF T-CELL ANTIGEN MONOCLONAL ANTIBODIES IN RENAL TRANSPLANTATION 1998 ·Transplantation ·John M. Kovarik, Christophe Gerbeau, François Legay, P L Amlot, Max H. Schreier, Michael Hall, Arne Schmidt	2
13	Disposition and immunodynamics of basiliximab in liver allograft recipients 1998 ·Clinical Pharmacology & Therapeutics ·John M. Kovarik, (unknown), Christophe Gerbeau, (unknown), (unknown), Björn Nashan	44
14	Pharmacokinetic-Pharmacodynamic Model Relating Spiraprilat Plasma Concentrations to Systemic and Regional Hemodynamic Effects in Congestive Heart Failure 1997 ·Journal of Cardiovascular Pharmacology ·Éric Bellissant, Nguyen Phong Chau, Christian Thuillez, Christophe Gerbeau, Christian Richard, Jean‐François Giudicelli	5
15	DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1 1997 ·Transplantation ·John M. Kovarik, P. Wolf, (unknown), G. Mourad, Yvon Lebranchu, P Lang, B. Bourbigot, Diego Cantarovich, Dominique Girault, Christophe Gerbeau, Arne Schmidt, J.P. Soulillou	99
16	Cyclosporine and Nonsteroidal Antiinflammatory Drugs: Exploring Potential Drug Interactions and Their Implications for the Treatment of Rheumatoid Arthritis 1997 ·The Journal of Clinical Pharmacology ·John M. Kovarik, E. Mueller, Christophe Gerbeau, Antoine Tarral, (unknown), M. Guerret	18
17	Evaluation of Pharmacokinetic Studies: Is It Useful to Take into Account Concentrations Below the Limit of Quantification? 1996 ·Pharmaceutical Research ·Henri Humbert, (unknown), (unknown), Christophe Gerbeau	2
18	Spirapril: pharmacokinetic properties and drug interactions. 1994 ·PubMed ·P. Graß, Christophe Gerbeau, Klaus Kutz	6
19	Radioimmunoassays for Spirapril and Its Active Metabolite Spiraprilate 1992 ·Therapeutic Drug Monitoring ·(unknown), (unknown), (unknown), Christophe Gerbeau, David W. Holt	4
20	A Radioreceptor Assay for Determination of Nicardipine in Human Serum Using³H(+)PN 200-110 as Radioligand 1990 ·Journal of Immunoassay ·Christophe Gerbeau, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact